A randomized trial of TLR-2 agonist CADI-05 targeting desmocollin-3 for advanced non-small-cell lung cancer† † This study was previously presented as: an oral presentation at the annual meeting of the American Society of Clinical Oncology (ASCO), June 3–6, 2011, Chicago, IL, USA, and at the 14th World conference on Lung Cancer, July 3–7, 2011, Amsterdam, Netherlands.
Titel:
A randomized trial of TLR-2 agonist CADI-05 targeting desmocollin-3 for advanced non-small-cell lung cancer† † This study was previously presented as: an oral presentation at the annual meeting of the American Society of Clinical Oncology (ASCO), June 3–6, 2011, Chicago, IL, USA, and at the 14th World conference on Lung Cancer, July 3–7, 2011, Amsterdam, Netherlands.